QuidelOrtho Corporation

NasdaqGS:QDEL Stock Report

Market Cap: US$2.0b

QuidelOrtho Past Earnings Performance

Past criteria checks 0/6

QuidelOrtho's earnings have been declining at an average annual rate of -61.2%, while the Medical Equipment industry saw earnings growing at 14.1% annually. Revenues have been growing at an average rate of 15.3% per year.

Key information

-61.23%

Earnings growth rate

-59.72%

EPS growth rate

Medical Equipment Industry Growth8.90%
Revenue growth rate15.34%
Return on equity-16.70%
Net Margin-17.01%
Last Earnings Update29 Jun 2025

Recent past performance updates

Recent updates

QuidelOrtho Corporation (NASDAQ:QDEL) Surges 32% Yet Its Low P/S Is No Reason For Excitement

May 14
QuidelOrtho Corporation (NASDAQ:QDEL) Surges 32% Yet Its Low P/S Is No Reason For Excitement

QuidelOrtho: Stagnant Growth Means Best To Avoid (Rating Downgrade)

May 12

QuidelOrtho (NASDAQ:QDEL) Has No Shortage Of Debt

Apr 25
QuidelOrtho (NASDAQ:QDEL) Has No Shortage Of Debt

QuidelOrtho Corporation's (NASDAQ:QDEL) Business And Shares Still Trailing The Industry

Mar 30
QuidelOrtho Corporation's (NASDAQ:QDEL) Business And Shares Still Trailing The Industry
User avatar

Leadership Changes And Cost Reductions Will Shape Future Profitability

Leadership changes and strategic initiatives aim for innovation and efficiency, enhancing revenue and net margins.

QuidelOrtho: Growth Struggles And Negative GAAP Earnings Continue To Disinterest Investors

Feb 20

QuidelOrtho: Highly Levered With Questionable Growth

Nov 26

Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) Low P/S

Nov 17
Lacklustre Performance Is Driving QuidelOrtho Corporation's (NASDAQ:QDEL) Low P/S

QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

Sep 15
QuidelOrtho (NASDAQ:QDEL) Seems To Be Using A Lot Of Debt

QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

Aug 09
QuidelOrtho Corporation (NASDAQ:QDEL) Stock Catapults 38% Though Its Price And Business Still Lag The Industry

QuidelOrtho: Attractive Valuation Despite Weak Performance

Apr 13

We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

Apr 08
We Think QuidelOrtho (NASDAQ:QDEL) Is Taking Some Risk With Its Debt

QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

Feb 15
QuidelOrtho Corporation's (NASDAQ:QDEL) 38% Dip In Price Shows Sentiment Is Matching Revenues

Revenue & Expenses Breakdown

How QuidelOrtho makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

NasdaqGS:QDEL Revenue, expenses and earnings (USD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
29 Jun 252,742-466742202
30 Mar 252,765-359749213
29 Dec 242,783-2,052767219
29 Sep 242,818-1,867767233
30 Jun 242,835-1,859775236
31 Mar 242,863-1,765766242
31 Dec 232,998-10763245
01 Oct 233,12213789250
02 Jul 233,16245799254
02 Apr 233,110118739226
01 Jan 233,266549621188
02 Oct 223,036810481152
03 Jul 222,7621,006340110
03 Apr 222,3261,00627199
02 Jan 221,69970424096
03 Oct 211,87188322395
04 Jul 211,83790021493
31 Mar 211,86294820891
03 Jan 211,66281018184
30 Sep 201,00537118374
30 Jun 2065515516864
31 Mar 205628816455
31 Dec 195357316253
30 Sep 195157516050
30 Jun 195066915851
31 Mar 195016515753
31 Dec 185227415352
30 Sep 185053715050
30 Jun 184382013344
31 Mar 183731211438
31 Dec 17278-89634
30 Sep 17216-58230
30 Jun 1721408032
31 Mar 1721547834
31 Dec 16192-147739
30 Sep 16189-127641
30 Jun 16187-127641
31 Mar 16183-147540
31 Dec 15194-67736
30 Sep 1520617635
30 Jun 15201-47638
31 Mar 15197-27337
31 Dec 14184-76938

Quality Earnings: QDEL is currently unprofitable.

Growing Profit Margin: QDEL is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: QDEL is unprofitable, and losses have increased over the past 5 years at a rate of 61.2% per year.

Accelerating Growth: Unable to compare QDEL's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: QDEL is unprofitable, making it difficult to compare its past year earnings growth to the Medical Equipment industry (12.6%).

Return on Equity

High ROE: QDEL has a negative Return on Equity (-16.7%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2025/10/05 11:18
End of Day Share Price 2025/10/03 00:00
Earnings2025/06/29
Annual Earnings2024/12/29

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

QuidelOrtho Corporation is covered by 23 analysts. 7 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Daniel OwczarskiAvondale Partners
Mark MassaroCanaccord Genuity
Patrick DonnellyCitigroup Inc